Titan Biotech LimitedBSE: TITANBIO

Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December, 2025.

· Issued by Titan Biotech Limited via BSE India

Filed with BSE · · 1 page · English

On 6ix: 6ix.com/news/board-meeting-intimation-for-consideration-and-approval-of-standalone-and-consolidated-financial-results-for-the-quarter-and-nine-months-ended-december-2025

Release

Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the unaudited standalone & consolidated financial results for the third quarter and nine months ended December 31, 2025.

Titan Biotech Limited on 6ix

Story so far

Earlier from Titan Biotech

Later from Titan Biotech

All Titan Biotech news releases